Repurposing anti-diabetic drug "Sitagliptin" as a novel virulence attenuating agent in Serratia marcescens.

Published in: PloS one (2020)

Sitagliptin is a promising anti-virulence agent against S. marcescens that may be beneficial in the control of healthcare associated infections caused by S. marcescens.

Keyphrases

healthcare
pseudomonas aeruginosa
escherichia coli
staphylococcus aureus
antimicrobial resistance
biofilm formation
type diabetes
cystic fibrosis